Researchers at Lund University in Sweden, have in collaboration with colleagues in Copenhagen and Singapore, mapped how the body’s own peptides act to reduce infection and inflammation by deactivating the toxic substances formed in the process.
The study is published in Nature Communications and the researchers believe their discovery could lead to new drugs against infection and inflammation, for example in wound healing.
The toxins that are neutralised, known as lipopolysaccharides (LPS), come from the bacterial cell walls and generate an inflammatory reaction. The reaction is a necessary part of our immune defence system in which our bodies respond quickly and fight invasive bacteria. However, it can be over-activated and become harmful, as observed in infected skin wounds, infections in various organs, or in the case of bacteria spreading to the blood, which can lead to sepsis.
“We know from previous studies what the task of these peptides is but now we have mapped how they proceed in gradually reducing an inflammatory reaction”, says Artur Schmidtchen, professor of dermatology and venereology at Lund University and consultant physician at Skåne University Hospital in Lund.
“By use of advanced biophysics such as nuclear magnetic resonance analysis, combined with molecular modelling and biological studies we show that these peptides form a C-shaped structure which enables the capturing and inactivation of LPS. They also simultaneously interfere with receptor-mediated inflammatory responses”, adds Rathi Saravanan, senior research fellow at Lee Kong Chian School of Medicine at Nanyang Technological University, Singapore, and first author of the study.
“Currently, most drugs aim to more or less completely block a target, such as a receptor. But that risks a deactivation of the immune defence system which can be detrimental and downright dangerous. The body’s own defence mechanisms proceed with greater caution in what is known as a transient manner: the peptides act on their target for a short time to reduce an inflammation towards normalisation. It is the natural functions of these peptides that we want to develop into new drugs”, says Artur Schmidtchen, who has been researching the field of innate immunity for over 20 years.
In addition, the peptides present in thrombin, a common blood protein, are multifunctional and can attack several targets, unlike current drugs.
The dermatology researchers now want to develop a peptide gel for improved wound healing in patient studies.
“That is the primary goal, but we will also be looking at the possibility of developing new drugs against infections in the eyes and various internal organs. This will become a new way of preventing both infection and inflammation without using antibiotics.”
The Latest on: Peptides
via Google News
The Latest on: Peptides
- Study uncovers new hurdle for developing immunotherapies on September 18, 2018 at 12:12 pm
Scientists knew there were many millions more peptides, or antigen targets, than TCRs. They expected that the receptors recognized and adjusted to many different peptides that have similar properties. […]
- Safe to Start Sacubitril/Valsartan Predischarge in Acute Heart Failure: TRANSITION on September 18, 2018 at 10:41 am
That study, called PIONEER-HF, also has a placebo-control group and measures changes in natriuretic peptides for the primary outcome. Tolerability is among the major issues with the novel agent that c... […]
- Feldan Therapeutics nabs $12.5 mln in GC-led Series A round on September 18, 2018 at 9:40 am
In past years, Feldan and its collaborators have shown that the Feldan Shuttle enables highly efficient delivery of proteins and peptides inside mammalian cells, both in vivo and ex vivo. Proceeds fro... […]
- Global Oral Proteins and Peptides Market Will Reach USD 1671.8 Million By 2024: Zion Market Research on September 13, 2018 at 10:20 pm
According to the report, global oral proteins and peptides market was valued at approximately USD 772.4 million in 2017 and is expected to reach around USD 1671.8 million by 2024, growing at a ... […]
- Creative Peptides Released GMP Synthesis Service on August 30, 2018 at 1:54 pm
Creative Peptides announced the launch of its GMP synthesis business on August 29, 2018. Located in Shirley, New York, the world’s leading peptide supplier Creative Peptides announced the launch of it... […]
- Global Soy Peptides Industry 2018 Market Report; Launched via MarketResearchReports.com on August 15, 2018 at 7:48 am
Lewes, DE -- (SBWIRE) -- 08/15/2018 -- In this report, we analyze the Soy Peptides industry from two aspects. One part is about its production and the other part is about its consumption. In terms of ... […]
- $1.33 Bn Collagen Peptides Market, 2023 on August 7, 2018 at 12:12 pm
The "Collagen Peptides Market by Source (Cattle Hide & Bones, Pigskin, and Poultry & Fish), Application (Nutritional Products, Snacks & Cereals, Dairy Products, Beverages, and Meat & Poultry Products) ... […]
- Nanoparticle vaccine made with peptides effective against influenza virus, study finds on July 30, 2018 at 12:19 pm
A new, double-layered nanoparticle vaccine made with peptides has been found to effectively protect mice against influenza A virus, according to a study led by Georgia State University. Influenza, a c... […]
- Researchers create matchmaking service for peptides and antibiotics on June 21, 2018 at 11:02 am
DJK-5 in combination with ciprofloxacin prevents biofilm development in the laboratory and shows enhanced removal of bacteria in skin abscesses. The image to the left shows a confocal scanning microsc... […]
via Bing News